title: Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
abstract: BACKGROUND
  Resveratrol, a naturally occurring stilbene, has been categorized as a phytoestrogen due to its ability to compete with natural estrogens for binding to estrogen receptor alpha (ERα) and modulate the biological responses exerted by the receptor. Biological effects of resveratrol (RES) on estrogen receptor alpha (ERα) remain highly controversial, since both estrogenic and anti-estrogenic properties were observed.
  
  
  RESULTS
  Here, we provide insight into the structural basis of the agonist/antagonist effects of RES on ERα ligand binding domain (LBD). Using atomistic simulation, we found that RES bound ERα monomer in antagonist conformation, where Helix 12 moves away from the ligand pocket and orients into the co-activator binding groove of LBD, is more stable than RES bound ERα in agonist conformation, where Helix 12 lays over the ligand binding pocket. Upon dimerization, the agonistic conformation of RES-ERα dimer becomes more stable compared to the corresponding monomer but still remains less stable compared to the corresponding dimer in antagonist conformation. Interestingly, while the binding pocket and the binding contacts of RES to ERα are similar to those of pure agonist diethylstilbestrol (DES), the binding energy is much less and the hydrogen bonding contacts also differ providing clues for the partial agonistic character of RES on ERα.
  
  
  CONCLUSIONS
  Our Molecular Dynamics simulation of RES-ERα structures with agonist and antagonist orientations of Helix 12 suggests RES action is more similar to Selective Estrogen Receptor Modulator (SERM) opening up the importance of cellular environment and active roles of co-regulator proteins in a given system. Our study reveals that potential co-activators must compete with the Helix 12 and displace it away from the activator binding groove to enhance the agonistic activity.
authors.forename: Sandipan
authors.initials: S
authors.lastname: Chakraborty
authors.affiliation: Laboratory of Computational Biophysics & Bioengineering, Department of Physics, Tougaloo College, 500 West County Line Road, Toogaloo, MS 39174, USA. alevenson@umc.edu.
authors.forename: Anait S
authors.initials: AS
authors.lastname: Levenson
authors.forename: Pradip K
authors.initials: PK
authors.lastname: Biswas
mesh_terms: D000818:Animals; D001665:Binding Sites; D004054:Diethylstilbestrol / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D019281:Dimerization; D004958:Estradiol / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D047628:Estrogen Receptor alpha / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D000077267:Fulvestrant; D006801:Humans; D006860:Hydrogen Bonding; D008024:Ligands; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D048789:Phytoestrogens / Q000737:chemistry* / Q000378:metabolism / Q000493:pharmacokinetics; D011487:Protein Conformation; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D000077185:Resveratrol; D013267:Stilbenes / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology*; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology
chemical_list: D047628:Estrogen Receptor alpha; D008024:Ligands; D048789:Phytoestrogens; D013267:Stilbenes; D013629:Tamoxifen; C016601:afimoxifene; D000077267:Fulvestrant; D004958:Estradiol; D004054:Diethylstilbestrol; D000077185:Resveratrol